Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

The NIH starts spending $1.5 billion in new Brain Research through Advancing Innovative Neuro-technologies (BRAIN) projects

___

NIH Starts to Spend $4.8 Bil­lion in “Extra” Cures Drug Research Mon­ey (P&T Com­mu­ni­ty):

The Nation­al Insti­tutes of Health (NIH) launched 110 new brain research projects in the fis­cal year end­ing last Sep­tem­ber (2017) with the first por­tion of the $1.5 bil­lion over 10 years it will hope­ful­ly receive from the 21st Cen­tu­ry Cures Act, which spread a total of $4.8 bil­lion over four NIH pro­grams. That is mon­ey over and above the NIH annu­al appro­pri­a­tion from Con­gress. The oth­er three “Inno­va­tion Funds” are: Pre­ci­sion Med­i­cine, Can­cer Moon­shot, and Regen­er­a­tive Med­i­cine.

The $1.5 bil­lion in new Brain Research through Advanc­ing Inno­v­a­tive Neu­ro-tech­nolo­gies (BRAIN) research mon­ey seems par­tic­u­lar­ly impor­tant giv­en the announce­ment in Jan­u­ary that Pfiz­er was end­ing its Alzheimer’s research pro­gram Read the rest of this entry »

With pharma exiting Alzheimer’s research, new hope (and urgency) seen in the combination of brain training and transcranial direct current stimulation (tDCS)

___

What does the future hold for the war on Alzheimer’s? (The Globe and Mail):

After spend­ing huge sums on clin­i­cal trails in recent years, the phar­ma­ceu­ti­cal indus­try has failed to find a drug that can halt the mind-rob­bing dis­ease. And this month, Pfiz­er announced it is end­ing its Alzheimer’s research, although oth­er com­pa­nies haven’t thrown in the tow­el yet. But oth­er pre­ven­tion mea­sures are being explored.

Sev­er­al Toron­to hos­pi­tals are involved in an ambi­tious $10-mil­lion, five-year study to deter­mine whether a com­bi­na­tion of cog­ni­tive reme­di­a­tion – men­tal exer­cis­es – plus elec­tri­cal stim­u­la­tion of the brain can delay Read the rest of this entry »

Akili raises an additional $11.9M; brings Amgen, Merck, Pfizer and Shire to the digital medicine table

akili-game—–

Akili Adds Amgen Ven­tures and M Ven­tures* to Series B Financ­ing, Increas­ing Round to $42.4 Mil­lion (press release):

Akili Inter­ac­tive Labs, Inc. (“Akili”), a dig­i­tal med­i­cine com­pa­ny devel­op­ing nov­el, non-phar­ma­co­log­i­cal ther­a­peu­tics and diag­nos­tics for cog­ni­tive dis­or­ders, today announced an $11.9 mil­lion expan­sion of its recent Series B financ­ing. Read the rest of this entry »

Harnessing brain training games to better research, prevent and treat Alzheimer’s Disease

HRAkili

Brain Train­ing Data­base: Trea­sure Trove for Pre­clin­i­cal Alzheimer’s Research? (Alz­fo­rum):

Some researchers think brain games in general—which adapt to each user’s cog­ni­tive ability—may one day serve as cog­ni­tive diag­nos­tics to Read the rest of this entry »

Brain Training and Cognitive Assessment Market Surpassed $1.3 Billion In 2013

Heads-up: We just announced a new intel­li­gence pack­age aimed at edu­ca­tion, health, gam­ing and tech­nol­o­gy exec­u­tives and inno­va­tors.

Many mar­ket reports pro­vide lit­tle val­ue for the mon­ey. This mar­ket report by Sharp­Brains is the pre­cise oppo­site. Its wealth of data and analy­sis pro­vides very valu­able strate­gic and busi­ness devel­op­ment guid­ance to orga­ni­za­tions at the fron­tier of health and well­ness,” says Alexan­dra More­house, VP of Brand Man­age­ment at Kaiser Per­ma­nente. Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

twitter_logo_header
RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.